Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06448390
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-06-03
Brief Title:
Exercise Training Study of Patients With Claudicatio Intermittens
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
Randomized Clinical Trial on the Effects of Home-based Five Plus Exercise Training
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to evaluate whether walking capacity in patients with intermittent claudication is improved more by home-based 5 exercise training than by current recommendations of daily walking
Detailed Description:
Patients with intermittent claudication will by a web-based program be randomized to either five plus training or walking at least 30 minutes three times per week During the five plus training the participants are standing in front of a wall which is used for support of the balance The body is lifted with the calf musculature to the maximal height that the subject can achieve This is repeated until pain is felt in the calf musculature Following the initiation of pain the subject performs five extra repetitions The five extra calf raises are included to secure induction of ischemia followed by reperfusion to secure maximal training effect
The patients are followed by absolute walking distance on a treadmill quality of life questionnaire and Ankle-brachial index
The patients are followed by absolute walking distance on a treadmill quality of life questionnaire and Ankle-brachial index
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None